NCT01282203View on ClinicalTrials.gov

Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevorane in Adult Patients Required General Anesthesia for Surgery in Terms of Quality of Anesthesia and Its Influence on Cardiovascular System in Common Clinical Practice

CompletedOBSERVATIONAL
Enrollment

1,122

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Anesthesia, General
Trial Locations (12)

100600

Site Reference ID/Investigator# 44446, Zhezqazghan

110000

Site Reference ID/Investigator# 51847, Kostanay

120008

Site Reference ID/Investigator# 64462, Kyzylorda

160000

Site Reference ID/Investigator# 51848, Shymkent

050000

Site Reference ID/Investigator# 51851, Almaty

050012

Site Reference ID/Investigator# 54703, Almaty

010000

Site Reference ID/Investigator# 51843, Astana

Site Reference ID/Investigator# 51844, Astana

Site Reference ID/Investigator# 54705, Astana

020000

Site Reference ID/Investigator# 51842, Kokshetau

090000

Site Reference ID/Investigator# 54704, Oral

071403

Site Reference ID/Investigator# 51845, Semey

All Listed Sponsors
lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01282203 - Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevorane in Adult Patients Required General Anesthesia for Surgery in Terms of Quality of Anesthesia and Its Influence on Cardiovascular System in Common Clinical Practice | Biotech Hunter | Biotech Hunter